Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Aricò E, Castiello L, Bracci L, Urbani F, Lombardo F, Bacigalupo I, Ancidoni A, Vanacore N, Falcione A, Reggiani C, Dutti GM, Maglie MG, Papa O, Bartoletti PL, Ozzella G, Bevilacqua N, Nicastri E, Belardelli F, Sconocchia G. Aricò E, et al. Among authors: bevilacqua n. Trials. 2021 Sep 3;22(1):584. doi: 10.1186/s13063-021-05367-6. Trials. 2021. PMID: 34479601 Free PMC article.
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.
Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C; TBNET Study Group. Migliori GB, et al. Among authors: bevilacqua n. Eur Respir J. 2009 Aug;34(2):387-93. doi: 10.1183/09031936.00009509. Epub 2009 Mar 12. Eur Respir J. 2009. PMID: 19282348 Free article.
Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020.
Palazzolo C, Maffongelli G, D'Abramo A, Lepore L, Mariano A, Vulcano A, Bartoli TA, Bevilacqua N, Giancola ML, Di Rosa E, Nicastri E. Palazzolo C, et al. Among authors: bevilacqua n. Euro Surveill. 2020 Jul;25(30):2001372. doi: 10.2807/1560-7917.ES.2020.25.30.2001372. Euro Surveill. 2020. PMID: 32734857 Free PMC article.
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection.
Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, Nicastri E, Bevilacqua N, Giancola ML, Corpolongo A, Ippolito G, Capobianchi MR, Castilletti C. Colavita F, et al. Among authors: bevilacqua n. Ann Intern Med. 2020 Aug 4;173(3):242-243. doi: 10.7326/M20-1176. Epub 2020 Apr 17. Ann Intern Med. 2020. PMID: 32302380 Free PMC article. No abstract available.
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19.
Mazzotta V, Cozzi-Lepri A, Colavita F, Lanini S, Rosati S, Lalle E, Mastrorosa I, Cimaglia C, Vergori A, Bevilacqua N, Lapa D, Mariano A, Bettini A, Agrati C, Piselli P, Girardi E, Castilletti C, Garbuglia AR, Vaia F, Nicastri E, Antinori A. Mazzotta V, et al. Among authors: bevilacqua n. Front Immunol. 2022 Apr 20;13:868020. doi: 10.3389/fimmu.2022.868020. eCollection 2022. Front Immunol. 2022. PMID: 35514955 Free PMC article. Clinical Trial.
162 results